Days and weeks do matter: a call for testing infants at risk of HIV acquisition at birth
- PMID: 36695365
- DOI: 10.1097/QAD.0000000000003468
Days and weeks do matter: a call for testing infants at risk of HIV acquisition at birth
Comment on
-
Hospitalization among infants who initiate antiretroviral therapy before 3 months of age.AIDS. 2023 Mar 1;37(3):435-445. doi: 10.1097/QAD.0000000000003422. Epub 2022 Nov 10. AIDS. 2023. PMID: 36695356 Free PMC article.
References
-
- Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial . Lancet 2013; 382:1555–1563.
-
- Anderson K, Iyun V, Eley BS, Rabie H, Ferreira T, Nuttall J, et al. Hospitalization among infants who initiate antiretroviral therapy before 3 months of age . AIDS 2023; 37:435–445.
-
- World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. July 2021. Available at: https://www.who.int/publications/i/item/9789240031593 [cited 2022 Nov 28].
-
- Tagarro A, Chan M, Zangari P, Ferns B, Foster C, De Rossi A, et al. Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children . J Acquir Immune Defic Syndr 2018; 79:269–276.
-
- Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M Jr, Chun TW, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant . N Engl J Med 2013; 369:1828–1835.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous